(CDAK) –
-
Form 25-NSE Codiak BioSciences, Inc. Filed by: Nasdaq Stock Market LLC
-
Form SC 13G/A Codiak BioSciences, Inc. Filed by: FMR LLC
-
Form 4 Codiak BioSciences, Inc. For: Mar 30 Filed by: Howze Yalonda
-
Form 4 Codiak BioSciences, Inc. For: Mar 29 Filed by: Sathyanarayanan Sriram
-
Form 4 Codiak BioSciences, Inc. For: Mar 28 Filed by: Bain Linda
-
Form 4 Codiak BioSciences, Inc. For: Mar 28 Filed by: Konstantinov Konstantin
-
Form 4 Codiak BioSciences, Inc. For: Mar 28 Filed by: WILLIAMS DOUGLAS E
-
Form 4 Codiak BioSciences, Inc. For: Mar 29 Filed by: Barna Nicole
-
Form NT 10-K Codiak BioSciences, Inc. For: Dec 31
-
Form 8-K Codiak BioSciences, Inc. For: Mar 27
-
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.60%
-
Form 8-K Codiak BioSciences, Inc. For: Mar 23
-
Codiak BioSciences (CDAK) to Pursue Asset Sale through Voluntary Chapter 11 Process
-
Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process
-
Codiak BioSciences (CDAK) Halted, News Pending
-
Form SC 13G/A Codiak BioSciences, Inc. Filed by: Laurion Capital Management LP
-
Form 4 Codiak BioSciences, Inc. For: Aug 16 Filed by: Bain Linda
-
Form 4 Codiak BioSciences, Inc. For: Aug 16 Filed by: Konstantinov Konstantin
-
Form 4 Codiak BioSciences, Inc. For: Feb 16 Filed by: Haddock Jason
-
Form 4 Codiak BioSciences, Inc. For: Aug 16 Filed by: WILLIAMS DOUGLAS E
-
Form 4 Codiak BioSciences, Inc. For: Feb 16 Filed by: Bernstein Karen
-
Form 4 Codiak BioSciences, Inc. For: Aug 16 Filed by: Sathyanarayanan Sriram
-
Form 4 Codiak BioSciences, Inc. For: Feb 16 Filed by: GILLIS STEVEN
-
Form 4 Codiak BioSciences, Inc. For: Feb 16 Filed by: COONEY CHARLES L
-
Form 4 Codiak BioSciences, Inc. For: Aug 16 Filed by: Barna Nicole
-
Form 4 Codiak BioSciences, Inc. For: Feb 16 Filed by: MELAS KYRIAZI THEO
-
Form 4 Codiak BioSciences, Inc. For: Aug 16 Filed by: Howze Yalonda
-
Form SC 13G/A Codiak BioSciences, Inc. Filed by: Flagship Ventures Fund V, L.P.
-
Form SC 13G Codiak BioSciences, Inc. Filed by: ARMISTICE CAPITAL, LLC
-
Form SC 13G/A Codiak BioSciences, Inc. Filed by: FMR LLC
-
Form SC 13G Codiak BioSciences, Inc. Filed by: Laurion Capital Management LP
-
Form 4 Codiak BioSciences, Inc. For: Jan 24 Filed by: Konstantinov Konstantin
-
Form 4 Codiak BioSciences, Inc. For: Jan 24 Filed by: Sathyanarayanan Sriram
-
Form 4 Codiak BioSciences, Inc. For: Jan 24 Filed by: Barna Nicole
-
Form 4 Codiak BioSciences, Inc. For: Jan 24 Filed by: Howze Yalonda
-
Form 4 Codiak BioSciences, Inc. For: Jan 24 Filed by: Mauro David J
-
Form 4 Codiak BioSciences, Inc. For: Jan 24 Filed by: Bain Linda
-
Form 4 Codiak BioSciences, Inc. For: Jan 24 Filed by: WILLIAMS DOUGLAS E
-
Form 4 Codiak BioSciences, Inc. For: Jan 19 Filed by: Bain Linda
-
Form 4 Codiak BioSciences, Inc. For: Jan 19 Filed by: Konstantinov Konstantin
-
Form 4 Codiak BioSciences, Inc. For: Jan 19 Filed by: WILLIAMS DOUGLAS E
-
Form 4 Codiak BioSciences, Inc. For: Jan 19 Filed by: Sathyanarayanan Sriram
-
Form 4 Codiak BioSciences, Inc. For: Jan 19 Filed by: Howze Yalonda
-
Form 4 Codiak BioSciences, Inc. For: Jan 19 Filed by: Barna Nicole
-
Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx Conference
-
Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
-
Codiak Biosciences Inc. (CDAK) PT Lowered to $1.20 at Goldman Sachs
-
Form 10-Q Codiak BioSciences, Inc. For: Sep 30
-
Form 8-K Codiak BioSciences, Inc. For: Nov 03
-
Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress
Back to CDAK Stock Lookup